ATE371439T1 - Granulat bestehend aus stärke und laktose - Google Patents

Granulat bestehend aus stärke und laktose

Info

Publication number
ATE371439T1
ATE371439T1 AT00402159T AT00402159T ATE371439T1 AT E371439 T1 ATE371439 T1 AT E371439T1 AT 00402159 T AT00402159 T AT 00402159T AT 00402159 T AT00402159 T AT 00402159T AT E371439 T1 ATE371439 T1 AT E371439T1
Authority
AT
Austria
Prior art keywords
starch
lactose
granules consisting
granules
test
Prior art date
Application number
AT00402159T
Other languages
English (en)
Inventor
Oliver Luhn
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres filed Critical Roquette Freres
Application granted granted Critical
Publication of ATE371439T1 publication Critical patent/ATE371439T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
AT00402159T 2000-07-27 2000-07-27 Granulat bestehend aus stärke und laktose ATE371439T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00402159A EP1175899B1 (de) 2000-07-27 2000-07-27 Granulat bestehend aus Stärke und Laktose

Publications (1)

Publication Number Publication Date
ATE371439T1 true ATE371439T1 (de) 2007-09-15

Family

ID=8173789

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00402159T ATE371439T1 (de) 2000-07-27 2000-07-27 Granulat bestehend aus stärke und laktose

Country Status (23)

Country Link
US (1) US6770368B2 (de)
EP (1) EP1175899B1 (de)
JP (1) JP4394313B2 (de)
KR (1) KR100869171B1 (de)
CN (1) CN1253148C (de)
AT (1) ATE371439T1 (de)
AU (1) AU785135B2 (de)
BR (1) BR0107036A (de)
CA (1) CA2353363C (de)
CZ (1) CZ303682B6 (de)
DE (1) DE60036205T2 (de)
ES (1) ES2292414T3 (de)
HU (1) HU229277B1 (de)
IL (1) IL148752A0 (de)
MX (1) MXPA01007666A (de)
NO (1) NO333750B1 (de)
NZ (1) NZ517931A (de)
PL (1) PL203778B1 (de)
RS (1) RS49931B (de)
RU (1) RU2286142C2 (de)
SK (1) SK286951B6 (de)
WO (1) WO2002009673A1 (de)
ZA (1) ZA200202178B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826549A1 (fr) * 2001-06-28 2003-01-03 Roquette Freres Procede de preparation d'un comprime edulcorant et comprime edulcorant ainsi obtenu.
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
FR2834894B1 (fr) * 2002-01-21 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de piribedil
FR2834891B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de 2-({2-methoxy-2-[3(trifluoromethyl)phenyl]ethyl}amino)ethyl4 -(2-(9h-fluoren-9-yl)acetyl]amino}ethyl)benzoate
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
FR2834897B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de testosterone
FR2834892B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de mitiglinide
FR2834893B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de perindopril
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
US20030228370A1 (en) * 2002-06-11 2003-12-11 Michel Serpelloni Orodispersible solid pharmaceutical form
FR2857593B1 (fr) * 2003-07-18 2005-10-14 Servier Lab Composition pharmaceutique orodispersible d'un compose antithrombotique
GB0329208D0 (en) * 2003-12-17 2004-01-21 Ici Plc Particulate materials
GB0523810D0 (en) * 2005-11-23 2006-01-04 Astrazeneca Ab Pharmaceutical compositions
FR2894475B1 (fr) * 2005-12-14 2008-05-16 Servier Lab Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine
EP2100610A4 (de) * 2006-12-07 2009-12-02 Daiichi Sankyo Co Ltd Pharmazeutische zusammensetzung mit niedrig substituierter hydroxypropylcellulose
TWI428151B (zh) * 2006-12-07 2014-03-01 Daiichi Sankyo Co Ltd 含有甘露醇或乳糖之固形製劑
TWI442947B (zh) * 2006-12-07 2014-07-01 Daiichi Sankyo Co Ltd 安定性經改善之薄膜塗覆製劑
WO2008072532A1 (ja) * 2006-12-07 2008-06-19 Daiichi Sankyo Company, Limited 貯蔵安定性が改善された医薬組成物
FR2933299B1 (fr) 2008-07-04 2012-02-03 Roquette Freres Mannitol orodispersible
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
WO2010092828A1 (ja) * 2009-02-12 2010-08-19 富士化学工業株式会社 崩壊性粒子組成物及びそれを用いた速崩壊性圧縮成型物
FR2944971B1 (fr) * 2009-04-30 2012-09-07 Roquette Freres Coagglomerats de mannitol et d'amidon granulaire comprimables et a ecoulement libre
RU2013102893A (ru) * 2010-06-23 2014-07-27 Колгейт-Палмолив Компани Инкапсуляция ингредиентов в лактозной матрице для получения активных инкапсулятов
FR2966828B1 (fr) 2010-11-02 2012-12-28 Roquette Freres Poudre de polysaccharide et de polyol, comprimable et de haute viscosite
JP5483482B2 (ja) * 2011-05-23 2014-05-07 三井製糖株式会社 糖液から固形物を製造する方法及び固形物
CN102516321A (zh) * 2011-12-08 2012-06-27 上海天伟生物制药有限公司 一种药用乳糖及其制备方法和用途
JP5276199B1 (ja) * 2012-03-23 2013-08-28 池田食研株式会社 多孔質顆粒の製造方法
US9522964B2 (en) * 2012-04-03 2016-12-20 Development, Inc. Micronized starch and methods for manufacturing same
CA2955845C (en) * 2014-07-21 2022-08-16 Roquette Freres Sugar compositions for tableting by direct compression
EP3002005A1 (de) 2014-09-30 2016-04-06 Molkerei Meggle Wasserburg GmbH & Co. Kg Direktkomprimierter Hilfsstoff auf Basis von Lactose, Cellulose und Stärke
EP3034070A1 (de) * 2014-12-18 2016-06-22 Omya International AG Verfahren zur Herstellung eines pharmazeutischen Abgabesystems
JP6544564B2 (ja) * 2015-04-20 2019-07-17 清水建設株式会社 模擬粉体、及び粉体飛散状態評価方法
US10820608B1 (en) 2015-10-26 2020-11-03 The Hershey Company Hard candy confections with low hygroscopicity
CN110248926B (zh) * 2017-01-24 2022-12-06 石药集团中奇制药技术（石家庄）有限公司 Lsd1抑制剂及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE575343A (de) * 1955-09-09
AT376147B (de) * 1980-12-15 1984-10-10 Gergely Gerhard Verfahren und vorrichtung zum granulieren eines pulvergemisches
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
US5043170A (en) * 1989-02-14 1991-08-27 Hoffmann-La Roche Inc. Animal feed composition containing a vitamin D metabolite
JPH0584054A (ja) * 1991-09-27 1993-04-06 Kunoole Shokuhin Kk スープまたはソース粉末もしくは顆粒の製造法
JP3349535B2 (ja) * 1993-01-12 2002-11-25 フロイント産業株式会社 球形顆粒の製造方法
JPH08298956A (ja) * 1995-05-10 1996-11-19 Ajinomoto Co Inc 顆粒状調味料の製造方法
JPH0937737A (ja) * 1995-05-25 1997-02-10 Tokiwa Kanpo Seiyaku:Kk 菊花含有健康食品
JP3611652B2 (ja) * 1995-10-30 2005-01-19 長谷川香料株式会社 コーティング粉末の製造方法
DE19603984A1 (de) * 1996-02-05 1997-08-07 Bayer Ag Granulate von Triazinen
JP3934179B2 (ja) * 1996-07-11 2007-06-20 不二製油株式会社 動物の体内へ摂取される物質からなる粉体を造粒する方法及び造粒物
JP3447042B2 (ja) * 1997-07-23 2003-09-16 フロイント産業株式会社 単一物質球形粒の製造方法

Also Published As

Publication number Publication date
NO20021424D0 (no) 2002-03-21
RS49931B (sr) 2008-09-29
US6770368B2 (en) 2004-08-03
EP1175899A1 (de) 2002-01-30
RU2286142C2 (ru) 2006-10-27
US20020035248A1 (en) 2002-03-21
DE60036205T2 (de) 2008-05-21
JP2002142690A (ja) 2002-05-21
PL203778B1 (pl) 2009-11-30
KR20020063868A (ko) 2002-08-05
MXPA01007666A (es) 2004-08-11
AU785135B2 (en) 2006-10-05
NO333750B1 (no) 2013-09-09
CA2353363C (fr) 2010-06-01
CA2353363A1 (fr) 2002-01-27
AU7990901A (en) 2002-02-13
CN1386064A (zh) 2002-12-18
SK3702002A3 (en) 2002-08-06
NO20021424L (no) 2002-03-21
SK286951B6 (sk) 2009-08-06
PL353056A1 (en) 2003-10-06
WO2002009673A1 (fr) 2002-02-07
CZ303682B6 (cs) 2013-03-06
NZ517931A (en) 2003-11-28
CZ2002978A3 (cs) 2002-06-12
YU22002A (sh) 2004-09-03
BR0107036A (pt) 2002-06-04
CN1253148C (zh) 2006-04-26
IL148752A0 (en) 2002-09-12
DE60036205D1 (de) 2007-10-11
RU2002111360A (ru) 2004-01-10
HU229277B1 (en) 2013-10-28
JP4394313B2 (ja) 2010-01-06
KR100869171B1 (ko) 2008-11-19
ZA200202178B (en) 2003-06-05
EP1175899B1 (de) 2007-08-29
HUP0203064A2 (en) 2003-03-28
ES2292414T3 (es) 2008-03-16

Similar Documents

Publication Publication Date Title
DE60036205D1 (de) Granulat bestehend aus Stärke und Laktose
ITRM920476A1 (it) Formulazioni galeniche contenenti ciclosporina.
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
WO2001005762A3 (de) Biphenylderivate, ihre herstellung und ihre verwendung als mtp-inhibitor
WO2001032646A3 (en) Sulfonamide derivatives
NO993539D0 (no) Ny formulering for inhalering som har en bulkdensitet ved helling fra 0,28 til 0,38 g/ml, en fremgangsmåte for fremstilling av formuleringen og anvendelse derav
TR200001603T2 (tr) Yeni bileşikler
WO2002041889A3 (en) Indolsulfonyl compounds useful in the treatment of cns disorders
AP2001002088A0 (en) 4,4-Biarylpiperidine derivatives with opiod receptor activity.
BG103930A (en) Eletriptan hemisulphate and caffeine containing pharmaceutical compositions
DK254787D0 (da) Farmaceutiske praeparater til behandling af sygdomme foraarsaget af oxidativt stress og indeholdende 2-phenyl.1,2-benziso-selenazol-3(2h)-on som aktiv bestanddel
DK0929234T3 (da) Tabletter indeholdende en sødemiddelblanding
NO302368B1 (no) Kinoksalinforbindelser, farmasöytiske preparater som inneholder slike, og anvendelse av forbindelsene for fremstilling av preparatene
ATE92752T1 (de) Spruehgetrocknete ibuprofen-zusammensetzungen.
NO995431D0 (no) Substituerte 3,3-diamino-2-propennitriler, deres fremstilling og anvendelse
IL162314A0 (en) Use of pyridine-2,4-dicarboxylic acid diamides andof pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition
HRP20080521T3 (en) Orodispersible pharmaceutical composition of an antithrombotic compound
FI923751A0 (fi) Hexahydrobenso/f/kinolinoner.
AP2001002369A0 (en) Pharmaceutical complex.
NO992298D0 (no) Konformasjonsbegrensede LH-RH analoger, anvendelse derav og farmas°ytiske sammensetninger inneholdende disse
ATE359770T1 (de) Antipyretisches präparat enhaltend xylitol
MX9202432A (es) Compuestos de 4,5-dihidro-1,4-benzotiazepin-3(2h)onas, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
NO20021429L (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
SE9803280D0 (sv) Novel compounds
WO2001090085A3 (de) 6-methyl-4-trihalogenmethyltriazinverbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties